Introduction
Drug induced acute angle closure glaucoma is a sight threatening ocular emergency condition, which can be present as acute painful diminution of vision, nausea and vomiting, headache, coloured halos following administration of topical or systemic medication. Here we report 3 patients developed bilateral drug induced non pupillary block secondary angle closure glaucoma following administration of oral chlorthalidone, mefenamic acid, topiramate. Clinically all patients showed bilateral simultaneous induced high myopia, shallow anterior chamber, occludable angles, choroidal effusion.
Case 1
60 year old male came with complaints of sudden onset painful diminution of vision in both eyes (BE) since1 day. He is known case of diabetic mellitus 5 years and systemic hypertension past 1 week, was on tablet metformin 500mg twice a day(BD) for 5 years and tablet telmesartan plus chlorthalidone (40/12.5mg) combination once daily for 1 week. On examination BCVA-RE 5/60 with -4.0 DS 6/6 LE-6/36 with -3.0 DS 6/6. Intraocular pressure (IOP) by using applanation tonometry (AT) showed RE-36mmHg LE -30mmHg. Gonioscopy revealed BE- grade1 appositional angle closure (shaffer’s grading). Anterior segment examination showed BE- circumcorneal congestion, shallow anterior chamber (Van Hericks grade1), 5mm sluggishly reacting pupil, pseudophakia (Figure 1). Fundus examination was within normal limits. Ultrasonogram B scan BE showed shallow choroidal detachment all four quadrant. We arrived at the diagnosis of BE-chlorthalidone induced secondary angle closure glaucoma. Patient was advised to stop chlorthalodone, started on BE- Timolol eye drops twice a day and homatropine eye drops twice a day. Five days later patient was symptomatically better, BCVA-BE 6/12 with -0.75 DS 6/6. IOP was RE-14mmHg LE-10mmHg. Gonioscopy showed open angle in BE. Anterior and posterior segment examination was with in normal limits (Figure 2).
Case 2
45 year old male presented with complaints of painful defective vision BE since 3 days. Past five days, he was on tablet topiramate 25mg once daily for headache. On examination BCVA- BE 5/60 with -5.0 DS 6/6, IOP BE showed 26mmHG. Gonioscopy revealed BE- grade 2 appositional angle closure (shaffer’s grading).Anterior segment examination showed bilateral circumcorneal congestion, shallow anterior chamber(Van Hericks grade 2), 5mm sluggishly reacting pupil, clear lens. Fundus examination was within normal limits. Ultrasonogram B scan showed bilateral shallow choroidal detachment all four quadrant. . We arrived at the diagnosis of BE- Topiramate induced secondary angle closure glaucoma. Patient was advised to stop tablet topiramate, started on timolol (0.5%) eye drops BD, homatropine (2%) TDS for 1 week. One week later patient was symptomatically better, BCVA-BE 6/6. IOP was RE-14mmHg LE-10mmHg. Gonioscopy showed open angle in BE. Anterior and posterior segment examination was with in normal limits.
Case 3
40 year old female presented with complaints of painful defective vision BE since 2 days. She was on tablet mefenamic acid 500mg BD for 3days for dysmenorrhea. On examination BCVA- BE 4/60 with -6.0 DS 6/9. IOP was BE- 32mmHg. Gonioscopy revealed BE- grade 1 appositional angle closure (shaffer’s grading). Anterior segment examination showed bilateral circumcorneal congestion, shallow anterior chamber (Van Hericks grade 1), 5mm sluggishly reacting pupil, clear lens. Fundus examination was within normal limits. Ultrasonogram B scan showed bilateral shallow choroidal detachment all four quadrant. . We arrived at the diagnosis of BE- Mefenamic acid induced secondary angle closure glaucoma. Patient was advised to stop tablet mefenamic acid, started on timolol (0.5%) eye drops BD, homatropine (2%) TDS for 1 week. One week later patient was symptomatically better, BCVA-BE 6/6. IOP was BE-14mmHg. Gonioscopy showed open angle in BE. Anterior and posterior segment examination was with in normal limits.
Table 1
Discussion
Drug induced angle closure glaucoma is a preventable cause of potential blindness. It caused by pupillary block and non-pupillary block mechanism.1, 2 In pupillary block angle closure, pupillary dilation increases iris-lens contact, which blocks aqueous drainage from posterior chamber, pushes peripheral iris against trabecular meshwork. In non-pupillary block angle closure, anterior rotation of ciliary body with or without choroidal effusion moves iris-lens diaphragm forward, which blocks trabecular meshwork. Some cases in non-pupillary block, cilary body swelling causes zonule laxity, facilitates lens thickening lead to pushing iris against trabecular meshwork. Apart from gonioscopy and ultrasonogram, ultrasound biomicroscopy and anterior segment optical coherence tomography also useful tool for diagnosis. Since treatment modality differs based on underlying mechanism, it is important to know the mechanism. Several drugs have been documented, causing non-pupillary block angle closure glaucoma 3, 4, 5, 6, 7, 8, 9 (Table 1). Treatment modalities include, stop the causative drug and start anti glaucoma medications with topical cycloplegic drug. Laser peripheral iridotomy was ineffective, since non-pupillary block is the underlying mechanism.
Conclusion
We would like to bring this sight threatening ophthalmic condition to the general clinicians attention, since those drugs are commonly used in day to day practice. Once the diagnosis is suspected, urgent referral is required for appropriate and prompt management, which will be potentially sight saving.